April 29 (Reuters) - AbbVie on Wednesday reported better-than-expected quarterly revenue and profit, fueled by demand for ...
Hosted on MSN
The price Americans pay for medicine has gotten horribly out of control. Here's how to fix it.
More than 300,000 Americans use a medication called Humira. Most of them are paying far too much for it. Humira, the brand name of AbbVie’s adalimumab, is prescribed to treat inflammatory diseases ...
The collaboration will make lower‑cost biosimilar alternatives to Humira and Stelara available to commercial members.
The last time I spoke about AbbVie Inc. (ABBV) it was in a Seeking Alpha article entitled as "AbbVie: Increased Outlook For 2025 And Expansions Merit Continued 'Strong Buy' Rating." For this article I ...
Though far from the first large drugmaker to strike a pricing deal with the Trump administration, AbbVie’s new accord is notable for the sheer size of the investment pledge that comes with it. Late ...
Dear Toni: I signed up for a supplemental Medicare Plan G and a Medicare Part D prescription drug plan, both of which started in January 2021. These two plans have served me well. I just received ...
Rebates aren’t disappearing, but PSG's 2026 survey suggests payers increasingly favor lower net costs, biosimilars and price ...
Humira's continued dominance after losing patent protection is one example of why the system for distributing drugs is broken. More than 300,000 Americans use a medication called Humira. Most of them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results